Back to Search
LOIS RAMONDETTA, M.D.
M.D.
Gynecologic Oncology Physician
NPI: 1801987508IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
K4538(TX)
CMS Specialties
PrimaryGYNECOLOGICAL ONCOLOGY
Additional
HOSPICE/PALLIATIVE CARE
Education
OTHER
Class of 1993
Research & Publications (20)
Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
PMID 19632709·Gynecol Oncol·2009
8-other
Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma.
PMID 19241422·Cancer·2009
3-trial
Advanced cervical cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapy.
PMID 16730784·Gynecol Oncol·2006
8-other
A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets.
PMID 13678720·Gynecol Oncol·2003
3-trial
Mentorship and productivity among gynecologic oncology fellows.
PMID 12825629·J Cancer Educ·2003
8-other
Treatment of uterine papillary serous carcinoma with paclitaxel.
PMID 11426978·Gynecol Oncol·2001
3-trial
Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
PMID 10656459·Clin Cancer Res·2000
8-other
Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning.
PMID 19110220·Am J Obstet Gynecol·2009
8-other
Ethnic disparities in cervical cancer survival among Medicare eligible women in a multiethnic population.
PMID 19258935·Int J Gynecol Cancer·2009
8-other
In vitro evaluation of the effects of gefitinib on the cytotoxic activity of selected anticancer agents in a panel of human endometrial cancer cell lines.
PMID 18753181·J Oncol Pharm Pract·2009
4-observational
In vitro evaluation of the effects of gefitinib on the modulation of cytotoxic activity of selected anticancer agents in a panel of human ovarian cancer cell lines.
PMID 17849119·Cancer Chemother Pharmacol·2008
8-other
Social factors affecting treatment of cervical cancer: ethical issues and policy implications.
PMID 18310380·Obstet Gynecol·2008
5-case
In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines.
PMID 18004570·Cancer Chemother Pharmacol·2008
8-other
Comparison of chemotherapy education and patient preferences in community versus academic gynecology oncology clinics.
PMID 18337438·J Oncol Pharm Pract·2008
4-observational
Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.
PMID 17869451·Int J Radiat Oncol Biol Phys·2008
4-observational
From technician to professional: integrating spirituality into medical practice.
PMID 17654378·Am J Bioeth·2007
8-other
Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.
PMID 16870239·Gynecol Oncol·2006
8-other
Clinical challenges presented by three simultaneous solid tumors.
PMID 17055558·Gynecol Oncol·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1801987508
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile